Long term (48-weeks) effectiveness, safety and tolerability of erenumab in the prevention of high-frequency episodic and chronic migraine in real-world: The early 2 study

Authors :: Bruno Mercuri
Angelo Pascarella
Domenico D'Amico
Davide Bertuzzo
Adriana Fallacara
Claudia Altamura
Laura Di Clemente
Michele Trimboli
Cinzia Finocchi
Fabio Frediani
Antonio Carnevale
Gabriella Egeo
Antonio Salerno
Florindo d’Onofrio
Roberta Messina
Carlemina Maria Costa
Lucia Manzo
Sabina Cevoli
Francesco Bono
Marco Aguggia
Licia Grazzi
Maria Albanese
Massimo Filippi
Paola Torelli
Cinzia Aurilia
Nicoletta Brunelli
Luisa Fofi
Valentina Favoni
Paola Di Fiore
Bruno Colombo
Maurizio Zucco
Piero Barbanti
Fabrizio Vernieri
Source :: Web of Science
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.

Subjects :: Pediatrics
medicine.medical_specialty
Chronic Migraine
Neurology
Tolerability
business.industry
medicine
Neurology (clinical)
business
Term (time)

Tools